Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12613]

New epigenomic block for advanced cancer progression

New epigenomic block for advanced cancer progression

Genome-wide risk associations for mucinous ovarian carcinoma

Genome-wide risk associations for mucinous ovarian carcinoma

Breast cancer metastasis gene identified

Breast cancer metastasis gene identified

$EHA 2015:Tolerability and efficacy data for ASP2215 in relapsed/refractory AML demonstrated in phase I/II trial$

EHA 2015:Tolerability and efficacy data for ASP2215 in relapsed/refractory AML demonstrated in phase I/II trial

Genomic testing can help identify patients at heightened risk for oesophageal cancer

Genomic testing can help identify patients at heightened risk for oesophageal cancer

EHA 2015: DNMT3A R882 mutations promote chemoresistance and residual disease in AML

EHA 2015: DNMT3A R882 mutations promote chemoresistance and residual disease in AML

EHA 2015: First randomised evidence for kinase inhibitor activity in acute myeloid leukaemia

EHA 2015: First randomised evidence for kinase inhibitor activity in acute myeloid leukaemia

EHA 2015: Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease progression

EHA 2015: Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease...

EHA 2015: Treatment and survival of patients with chronic myeloid leukemia (CML) in Europe

EHA 2015: Treatment and survival of patients with chronic myeloid leukemia (CML) in Europe

EHA 2015: Does the patient with myelofibrosis feel better through pacritinib?

EHA 2015: Does the patient with myelofibrosis feel better through pacritinib?

More from ecancer